Iterum Therapeutics Plc

NASDAQ:ITRM   9:36:10 AM EDT
0.53
-0.01 (-1.34%)
Other Pre-Announcement

Iterum Therapeutics Reports Second Quarter 2021 Financial Results

Published: 08/13/2021 11:31 GMT
Iterum Therapeutics Plc (ITRM) - Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update.
Iterum Therapeutics Plc - Qtrly Earnings per Share $0.04.
Iterum Therapeutics Plc - Qtrly Adjusted Loss per Share $0.04.
Iterum Therapeutics Plc - As of June 30, 2021, Had Cash, Cash Equivalents and Short-term Investments of $91.4 Million.
Iterum Therapeutics Plc - Expects Current Cash, Cash Equivalents, Short-term Investments Will Be Sufficient to Fund Its Operations Into H2 2023.